Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/EBITDA ratio high or low?
The EV/EBITDA ratio of 260.73x is 541% above its estimated 5-year average of 40.70x, near the high end of its estimated 5-year range (10.69x–335.02x).
As of 2026-10-06T14:41:31.434Z. 151.83% above its estimated 12-month average of 103.53x.
Calculation as of: 2026-10-06T14:41:31.434Z.
Quote observation: 2026-10-06T14:34:16.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c683fbcf7a5be6196b34cb829f91a73ddbf07994c0e1e68d76d832115efef523
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
260.73x
EV/EBITDA RATIO AVG TTM
103.53x
EV/EBITDA RATIO AVG 3Y
74.56x
EV/EBITDA RATIO AVG 5Y
40.70x
EV/EBITDA RATIO AVG 10Y
100.93x
EV/EBITDA RATIO AVG 15Y
100.93x
EV/EBITDA RATIO AVG 20Y
108.58x
CURRENT VS TTM AVG
+151.83%
CURRENT VS 3Y AVG
+249.67%
CURRENT VS 5Y AVG
+540.59%
CURRENT VS 10Y AVG
+158.32%
CURRENT VS 15Y AVG
+158.32%
CURRENT VS 20Y AVG
+140.13%
SECTOR MEDIAN · HEALTHCARE
15.66x
median of 177 covered companies
CURRENT VS SECTOR MEDIAN
+1564.94%
vs the sector median at left
Champions Oncology, Inc.
Market Cap
$69.26M
EV/EBITDA Ratio
260.73x
TTM Avg
103.53x
3Y Avg
74.56x
5Y Avg
40.70x
Market Cap
$71.89M
EV/EBITDA Ratio
N/A
TTM Avg
161.81x
3Y Avg
161.81x
5Y Avg
161.81x
Market Cap
$64.94M
EV/EBITDA Ratio
N/A
TTM Avg
250.18x
3Y Avg
250.18x
5Y Avg
250.18x
Market Cap
$64.31M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Champions Oncology, Inc. (CSBR) | $69.26M | 260.73x | 103.53x | 74.56x | 40.70x |
| iBio, Inc. (IBIO)vs › | $68.49M | N/A | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIO)vs › | $67.60M | N/A | N/A | N/A | N/A |
| MindWalk Holdings Corp. (HYFT)vs › | $71.89M | N/A | 161.81x | 161.81x | 161.81x |
| Cingulate Inc. (CING)vs › | $65.59M | 0.22x | 0.03x | 0.03x | 0.03x |
| Gain Therapeutics, Inc. (GANX)vs › | $72.73M | N/A | N/A | N/A | N/A |
| Heron Therapeutics, Inc. (HRTX)vs › | $64.94M | N/A | 250.18x | 250.18x | 250.18x |
| PDS Biotechnology Corporation (PDSB)vs › | $64.31M | N/A | N/A | N/A | N/A |
| Gossamer Bio, Inc. (GOSS)vs › | $64.56M | N/A | N/A | N/A | N/A |
| Alps Group Inc (ALPS)vs › | $63.23M | N/A | N/A | N/A | N/A |
At 260.7, EV/EBITDA is above its estimated 20-year median — higher than 76% of readings in its estimated 20-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 20-year low
10.7
median
86.4
estimated 20-year high
1131.3
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-10-05 | 260.08x |
| 2026-10-02 | 258.65x |
| 2026-10-01 | 255.78x |
| 2026-09-30 | 261.51x |
| 2026-09-29 | 251.48x |
| 2026-09-28 | 258.17x |
| 2026-09-25 | 256.74x |
| 2026-09-24 | 259.12x |
| 2026-09-23 | 262.47x |
| 2026-09-22 | 275.36x |
| 2026-09-21 | 273.93x |
| 2026-09-18 | 275.84x |
| 2026-09-17 | 265.33x |
| 2026-09-16 | 259.12x |
| 2026-09-15 | 250.53x |
| 2026-09-14 | 257.69x |
| 2026-09-11 | 296.50x |
| 2026-09-10 | 296.50x |
| 2026-09-09 | 291.25x |
| 2026-09-08 | 293.58x |
| 2026-09-04 | 303.51x |
| 2026-09-03 | 307.01x |
| 2026-09-02 | 299.42x |
| 2026-09-01 | 290.67x |
| 2026-08-31 | 290.67x |
| 2026-08-28 | 286.58x |
| 2026-08-27 | 291.83x |
| 2026-08-26 | 286.00x |
| 2026-08-25 | 289.50x |
| 2026-08-24 | 288.92x |
| 2026-08-21 | 288.33x |
| 2026-08-20 | 301.17x |
| 2026-08-19 | 287.16x |
| 2026-08-18 | 295.92x |
| 2026-08-17 | 292.42x |
| 2026-08-14 | 294.75x |
| 2026-08-13 | 295.34x |
| 2026-08-12 | 287.75x |
| 2026-08-11 | 290.08x |
| 2026-08-10 | 298.84x |
| 2026-08-07 | 301.76x |
| 2026-08-06 | 301.76x |
| 2026-08-05 | 308.18x |
| 2026-08-04 | 316.93x |
| 2026-08-03 | 335.02x |
| 2026-07-31 | 311.68x |
| 2026-07-30 | 305.84x |
| 2026-07-29 | 317.51x |
| 2026-07-28 | 321.60x |
| 2026-03-12 | 20.09x |
| 2026-03-11 | 20.67x |
| 2026-03-10 | 20.67x |
| 2026-03-09 | 20.92x |
| 2026-03-06 | 20.56x |
| 2026-03-05 | 20.05x |
| 2026-03-04 | 21.03x |
| 2026-03-03 | 21.03x |
| 2026-03-02 | 21.29x |
| 2026-02-27 | 20.89x |
| 2026-02-26 | 21.00x |
| 2026-02-25 | 20.96x |
| 2026-02-24 | 20.30x |
| 2026-02-23 | 20.49x |
| 2026-02-20 | 20.38x |
| 2026-02-19 | 21.21x |
| 2026-02-18 | 20.34x |
| 2026-02-17 | 20.49x |
| 2026-02-13 | 21.32x |
| 2026-02-12 | 20.85x |
| 2026-02-11 | 20.67x |
| 2026-02-10 | 21.47x |
| 2026-02-09 | 23.04x |
| 2026-02-06 | 23.04x |
| 2026-02-05 | 22.96x |
| 2026-02-04 | 23.14x |
| 2026-02-03 | 25.15x |
| 2026-02-02 | 25.15x |
| 2026-01-30 | 25.80x |
| 2026-01-29 | 26.20x |
| 2026-01-28 | 26.93x |
| 2026-01-27 | 27.19x |
| 2026-01-26 | 24.06x |
| 2026-01-23 | 23.76x |
| 2026-01-22 | 24.42x |
| 2026-01-21 | 25.00x |
| 2026-01-20 | 24.67x |
| 2026-01-16 | 25.44x |
| 2026-01-15 | 25.29x |
| 2026-01-14 | 25.33x |
| 2026-01-13 | 24.89x |
| 2026-01-12 | 23.65x |
| 2026-01-09 | 23.87x |
| 2026-01-08 | 23.91x |
| 2026-01-07 | 23.76x |
| 2026-01-06 | 23.25x |
| 2026-01-05 | 23.62x |
| 2026-01-02 | 23.44x |
| 2025-12-31 | 24.35x |
| 2025-12-30 | 23.04x |
| 2025-12-29 | 24.31x |
| 2025-12-26 | 24.60x |
| 2025-12-24 | 24.86x |
| 2025-12-23 | 24.93x |
| 2025-12-22 | 25.58x |
| 2025-12-19 | 25.48x |
| 2025-12-18 | 25.48x |
| 2025-12-17 | 22.20x |
| 2025-12-16 | 23.69x |
| 2025-12-15 | 22.59x |
| 2025-12-12 | 19.32x |
| 2025-12-11 | 18.05x |
| 2025-12-10 | 17.63x |
| 2025-12-09 | 17.96x |
| 2025-12-08 | 17.93x |
| 2025-12-05 | 17.26x |
| 2025-12-04 | 17.45x |
| 2025-12-03 | 17.11x |
| 2025-12-02 | 17.32x |
| 2025-12-01 | 17.14x |
| 2025-11-28 | 18.78x |
| 2025-11-26 | 18.66x |
| 2025-11-25 | 18.66x |
| 2025-11-24 | 18.78x |
| 2025-11-21 | 19.47x |
| 2025-11-20 | 19.14x |
| 2025-11-19 | 19.71x |
| 2025-11-18 | 19.71x |
| 2025-11-17 | 19.41x |
| 2025-11-14 | 19.56x |
| 2025-11-13 | 19.87x |
| 2025-11-12 | 19.77x |
| 2025-11-11 | 20.17x |
| 2025-11-10 | 19.50x |
| 2025-11-07 | 19.38x |
| 2025-11-06 | 19.80x |
| 2025-11-05 | 19.56x |
| 2025-11-04 | 19.44x |
| 2025-11-03 | 19.56x |
| 2025-10-31 | 19.68x |
| 2025-10-30 | 19.59x |
| 2025-10-29 | 19.44x |
| 2025-10-28 | 19.56x |
| 2025-10-27 | 19.62x |
| 2025-10-24 | 19.83x |
| 2025-10-23 | 19.41x |
| 2025-10-22 | 19.26x |
| 2025-10-21 | 19.08x |
| 2025-10-20 | 18.75x |
| 2025-10-17 | 18.63x |
| 2025-10-16 | 18.84x |
| 2025-10-15 | 18.90x |
| 2025-10-14 | 18.99x |
| 2025-10-13 | 18.69x |
| 2025-10-10 | 18.78x |
| 2025-10-09 | 18.84x |
| 2025-10-08 | 18.56x |
| 2025-10-07 | 18.78x |
| 2025-10-06 | 18.41x |
| 2025-10-03 | 18.05x |
| 2025-10-02 | 18.32x |
| 2025-10-01 | 18.35x |
| 2025-09-30 | 18.59x |
| 2025-09-29 | 18.29x |
| 2025-09-26 | 18.05x |
| 2025-09-25 | 18.32x |
| 2025-09-24 | 18.50x |
| 2025-09-23 | 19.02x |
| 2025-09-22 | 19.41x |
| 2025-09-19 | 18.87x |
| 2025-09-18 | 19.26x |
| 2025-09-17 | 18.20x |
| 2025-09-16 | 20.08x |
| 2025-09-15 | 17.03x |
| 2025-09-12 | 13.92x |
| 2025-09-11 | 13.13x |
| 2025-09-10 | 13.09x |
| 2025-09-09 | 13.45x |
| 2025-09-08 | 13.85x |
| 2025-09-05 | 13.94x |
| 2025-09-04 | 14.11x |
| 2025-09-03 | 14.17x |
| 2025-09-02 | 14.40x |
| 2025-08-29 | 13.85x |
| 2025-08-28 | 13.47x |
| 2025-08-27 | 13.43x |
| 2025-08-26 | 13.70x |
| 2025-08-25 | 14.40x |
| 2025-08-22 | 15.61x |
| 2025-08-21 | 15.15x |
| 2025-08-20 | 14.95x |
| 2025-08-19 | 15.59x |
| 2025-08-18 | 14.21x |
| 2025-08-15 | 13.26x |
| 2025-08-14 | 13.26x |
| 2025-08-13 | 13.94x |
| 2025-08-12 | 13.28x |
| 2025-08-11 | 12.96x |
| 2025-08-08 | 13.03x |
| 2025-08-07 | 12.39x |
| 2025-08-06 | 13.32x |
| 2025-08-05 | 13.11x |
| 2025-08-04 | 12.96x |
| 2025-08-01 | 12.49x |
| 2025-07-31 | 12.83x |
| 2025-07-30 | 13.03x |
| 2025-07-29 | 13.05x |
| 2025-07-28 | 12.79x |
| 2025-07-25 | 12.66x |
| 2025-07-24 | 13.53x |
| 2025-07-23 | 14.33x |
| 2025-07-22 | 14.51x |
| 2025-07-21 | 14.84x |
| 2025-07-18 | 14.80x |
| 2025-07-17 | 15.43x |
| 2025-07-16 | 14.42x |
| 2025-07-15 | 14.42x |
| 2025-07-14 | 14.73x |
| 2025-07-11 | 14.96x |
| 2025-07-10 | 16.24x |
| 2025-07-09 | 16.42x |
| 2025-07-08 | 16.26x |
| 2025-07-07 | 16.38x |
| 2025-07-03 | 14.21x |
| 2025-07-02 | 14.37x |
| 2025-07-01 | 13.36x |
| 2025-06-30 | 13.65x |
| 2025-06-27 | 14.35x |
| 2025-06-26 | 13.38x |
| 2025-06-25 | 14.01x |
| 2025-06-24 | 14.39x |
| 2025-06-23 | 14.89x |
| 2025-06-20 | 15.31x |
| 2025-06-18 | 15.50x |
| 2025-06-17 | 14.87x |
| 2025-06-16 | 14.08x |
| 2025-06-13 | 14.17x |
| 2025-06-12 | 13.71x |
| 2025-06-11 | 11.67x |
| 2025-06-10 | 12.02x |
| 2025-06-09 | 12.27x |
| 2025-06-06 | 12.79x |
| 2025-06-05 | 12.09x |
| 2025-06-04 | 11.87x |
| 2025-06-03 | 11.96x |
| 2025-06-02 | 10.69x |
| 2025-05-30 | 10.96x |
| 2025-05-29 | 11.51x |
| 2025-05-28 | 11.15x |
| 2025-05-27 | 11.17x |
| 2025-05-23 | 10.83x |
| 2025-05-22 | 10.85x |
| 2025-05-21 | 11.15x |
| 2025-05-20 | 11.55x |
| 2025-05-19 | 11.05x |
| 2025-05-16 | 11.82x |
| 2025-05-15 | 11.69x |
| 2025-05-14 | 12.03x |
| 2025-05-13 | 11.64x |
| 2025-05-12 | 11.19x |
| 2025-05-09 | 11.58x |
Showing the most recent 260 of 1,499 data points. The chart above shows the full history.
